Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aquestive Therapeutics Inc.

3.94
-0.0800-1.99%
Post-market: 3.940.00000.00%19:47 EDT
Volume:712.43K
Turnover:2.81M
Market Cap:391.35M
PE:-6.70
High:4.07
Open:4.02
Low:3.88
Close:4.02
Loading ...

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

GlobeNewswire
·
04 Aug

Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
01 Aug

Aquestive Therapeutics Promotes Sherry Korczynski to Chief Commercial Officer Amid Strategic Expansion

Reuters
·
22 Jul

Aquestive Therapeutics provides international expansion update for Anaphylm

TIPRANKS
·
15 Jul

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire
·
15 Jul

Aquestive Therapeutics Inc. to Participate in Leerink Partners Therapeutics Forum on I&I and Metabolism

Reuters
·
07 Jul

Aquestive Therapeutics announces two presentations on Anaphylm

TIPRANKS
·
25 Jun

Aquestive Therapeutics Unveils Promising Data on Anaphylm™ Sublingual Film for Severe Allergic Reactions at CFAAR Summit

Reuters
·
25 Jun

Aquestive Therapeutics (AQST) Gets a Buy from Raymond James

TIPRANKS
·
17 Jun

Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
16 Jun

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application for Anaphylm™ with PDUFA Date Set for January 31, 2026

Reuters
·
16 Jun

Aquestive Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
12 Jun

Those who invested in Aquestive Therapeutics (NASDAQ:AQST) three years ago are up 128%

Simply Wall St.
·
26 May

Aquestive Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
15 May

Aquestive Therapeutics' Shares Fall to 52-Week Low on 1Q Results, Outlook Cut

Dow Jones
·
13 May

Aquestive Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
10 May

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference

GlobeNewswire
·
05 May

Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
02 May